Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIARA: Tacrolimus in Active Rheumatoid Arthritis
NCT01746680Phase 4Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Aug 2012
- Primary completion
- Jun 2015
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in rheumatoid arthritis (RA), sponsored by Chong Kun Dang Holdings. Started Aug 2012; status: completed.
02
Drugs
tacrolimus
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01746680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01746680.